Jacobio Pharma: Focus on Novel Targets
An in-depth overview of the proposed listing of Jacobio Pharmaceuticals using a framework that touches on the science, market opportunity,...
339 Views
Betta Pharmaceuticals (300558.SZ) - The Harvest Season Is Coming
Icotinib hydrochloride ensures stable cash flow for Betta for years. Icotinib hydrochloride is a National Class 1.1 new drug that is independently...
297 Views
Major Indexes Testing Resistance
Positive news flow surrounding COVID-19 is encouraging on many fronts. Still, despite encouraging news and the relief rally in global equities,...
320 Views
Zai Lab IPO: Thoughts on Valuation, Risks and Upsides (Part 2)
In our first insight, we covered the company's background, particularly its management team and its product pipeline.In this insight, we will...
2k Views
Zai Lab IPO: Experienced Team, Promising In-Licensing Drug Pipeline (Part 1)
Zai Lab is looking to raise US$100m in the US listing. The company has a short history of three years and does not have a commercial product at the...
1.5k Views